![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, February 09, 2023 7:44:30 AM
We all know results from testing the HIV vaccine are pending. And how could it be any different when the company actively seeks for a sale of the company that Mr. Kempers knows the results? I think nobody would try that in this situation. Therefore I am pretty sure Mr. Kempers knows either about poor results and they just want to sell the rest of the company (in particular the birch pollen project, probably) or he knows about a good outcome from the HIV tests and they think it's an ideal situation to sell the company instead of financing making the vaccine ready for the market.
In either way I think we should know the results, because potential buyers will surely get them. So, why don't we get them? Are these secret?
In any case this lack of information prevents me from making profound investment decisions.
My impression is that we got contradictory signs. Recently I wrote it: On the one hand Mr. Kempers executes options (I think he paid for the shares. Hope I am right in this) and on the other hand many other options don't get touched. I don't know what will happen to these in the case of a sale of the company. Will they expire or will the owners be compensated? If the latter is true, I wouldn't be concerned and Mr. Kempers exercise may have been a friendly hint to us shareholders.
Everything depends on the HIV vaccine, now. The company has immense debt. If I am right, everything below about 80 million would mean a total loss for us. Probably many shareholders would need at least 100 million to not loose money.
To get to the point: I know nothing and can't make decisions.
I am curious about todays trading as well.
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM